Virology Specimen Collection Market worth $5.4 billion by 2026 – Growth Rate, opportunities, and Forecast

According to the new market research report “Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type (Blood, Cervical, Nasal, Nasopharyngeal, Throat, Oral), Region-Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 5.4 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of -0.6%.

Driver: Rising prevalence of viral diseases and emergence of newer pathogens;

The Zika virus and Babesia outbreaks, alongside announcements for their inclusion in virology specimen collection tests, indicate the need for innovation in virology specimen collection technologies, consumables, and instruments. Other countries have also undertaken initiatives to check for new and emerging diseases. For example, the prevalence of malaria in African regions and the possibility of mosquito-borne transfer of Zika has resulted in mandates for Zika virus screening in the region.

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150226807

Virology Specimen Collection Market
Virology Specimen Collection Market

The Rising number of blood donations are among the factors. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the market.

In 2020, virology transport media segment accounted for the largest share of the virology specimen collection market;

The virology specimen collection market is segmented into viral transport media, swabs, blood collection kits, and specimen collection tubes. The viral transport media accounted for the largest share of the virology specimen collection market in 2020, mainly due to the rising number of blood donations, and the emergence of new pathogens.

In 2020, nasopharyngeal sample segment accounted for the largest share in the market;

The virology specimen collection market is segmented blood, cervical, nasal, nasopharyngeal, throat, oral, and other (conjunctiva, feces, nasopharyngeal aspirate or wash, urethral, urine samples, semen, sputum, and cerebrospinal fluid) samples. In 2020, nasopharyngeal samples accounted for the largest share of the virology specimen collection market. The large share of this segment can be attributed primarily due to the fast detection of transfusion transmissible infection (TTIs), and the increasing prevalence of HPV-related cancers (all cervical cancers) & human papillomavirus (HPV).

Request Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=150226807

The global Virology Specimen Collection Market is segmented into four major regions, namely, North America, Europe, the Asia Pacific and Rest of the World. In 2020, North America accounted for the largest share of the market. The large share of this region can be attributed to increasing number of blood donations in the region.

The major players operating in virology specimen collection market are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific, Inc. (US), Trinity Biotech (Ireland), Titan Biotech, Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.p.A. (Italy), Puritan Medical Products, Co. (Guilford, ME) and Hardy Diagnostics (US).

Becton, Dickinson and Company is one of the leading company in the market. BD manufacturers and markets laboratory equipment, diagnostic products, and medical instrument systems & reagents. The company operates its business through three segments—BD Medical, BD Life Sciences, and BD Interventional. In June 2020, BD announced the CE Mark and market launch of the BD Vacutainer UltraTouch Blood collection set.

Speak to Analysthttps://www.marketsandmarkets.com/speaktoanalystNew.asp?id=150226807